In addition, participants with obesity at the initial assessment had significantly higher ALT, triglycerides, and ApoB concentrations than overweight and normal-BMI participants at the initial assessment and this difference disappeared at the annual assessment. The gene discussed is GPT; the disease is obesity due to melanocortin 4 receptor deficiency.